Related references
Note: Only part of the references are listed.Myocardial glucotoxicity: Mechanisms and potential therapeutic targets
Sylvain Battault et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2020)
Cardiac sodium-dependent glucose cotransporter 1 is a novel mediator of ischaemia/reperfusion injury
Zhao Li et al.
CARDIOVASCULAR RESEARCH (2019)
DNA methylation reprograms cardiac metabolic gene expression in end-stage human heart failure
Mark E. Pepin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2019)
Cardiac ischemia-reperfusion injury under insulin-resistant conditions: SGLT1 but not SGLT2 plays a compensatory protective role in diet-induced obesity
Akira Yoshii et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Potential mechanisms underlying the cardiovascular benefits of sodium glucose cotransporter 2 inhibitors: a systematic review of data from preclinical studies
Ken Lee Chin et al.
CARDIOVASCULAR RESEARCH (2019)
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
S. D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Sotagliflozin: a dual sodium-glucose co-transporter-1 and-2 inhibitor for the management of Type 1 and Type 2 diabetes mellitus
H. Sims et al.
DIABETIC MEDICINE (2018)
Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2
Chiara Ghezzi et al.
DIABETOLOGIA (2018)
Chronic Pressure Overload Induces Cardiac Hypertrophy and Fibrosis via Increases in SGLT1 and IL-18 Gene Expression in Mice
Naoko Matsushita et al.
INTERNATIONAL HEART JOURNAL (2018)
Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure
Mary E. Sweet et al.
BMC GENOMICS (2018)
Inhibitor binding mode and allosteric regulation of Na+-glucose symporters
Paola Bisignano et al.
NATURE COMMUNICATIONS (2018)
Sodium-dependent glucose transporters (SGLT) in human ischemic heart: A new potential pharmacological target
Alessandra Di Franco et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Expression profiling and immunolocalization of Na+-d-glucose-cotransporter 1 in mice employing knockout mice as specificity control indicate novel locations and differences between mice and rats
Ivana Vrhovac Madunic et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2017)
Sodium-myoinositol cotransporter-1, SMIT1, mediates the production of reactive oxygen species induced by hyperglycemia in the heart
Anne Van Steenbergen et al.
SCIENTIFIC REPORTS (2017)
Metabolism and acetylation contribute to leucine-mediated inhibition of cardiac glucose uptake
Edith Renguet et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2017)
Inhibition of SGLT1 abrogates preconditioning-induced cardioprotection against ischemia-reperfusion injury
Abhinav Kanwal et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus
Panai Song et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
SGLT inhibitors attenuate NO-dependent vascular relaxation in the pulmonary artery but not in the coronary artery
Ying Han et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Localizations of Na+-D-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart
Ivana Vrhovac et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2015)
Expression of SGLT1 in Human Hearts and Impairment of Cardiac Glucose Uptake by Phlorizin during Ischemia-Reperfusion Injury in Mice
Yusuke Kashiwagi et al.
PLOS ONE (2015)
AMPK activation by glucagon-like peptide-1 prevents NADPH oxidase activation induced by hyperglycemia in adult cardiomyocytes
Magali Balteau et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2014)
Transgenic Knockdown of Cardiac Sodium/Glucose Cotransporter 1 (SGLT1) Attenuates PRKAG2 Cardiomyopathy, Whereas Transgenic Overexpression of Cardiac SGLT1 Causes Pathologic Hypertrophy and Dysfunction in Mice
Mohun Ramratnam et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
The SLC2 (GLUT) family of membrane transporters
Mike Mueckler et al.
MOLECULAR ASPECTS OF MEDICINE (2013)
Cardiac PI3K-Akt Impairs Insulin-Stimulated Glucose Uptake Independent of mTORC1 and GLUT4 Translocation
Yi Zhu et al.
MOLECULAR ENDOCRINOLOGY (2013)
Bridging the gap between structure and kinetics of human SGLT1
Monica Sala-Rabanal et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2012)
Na+-D-glucose Cotransporter SGLT1 is Pivotal for Intestinal Glucose-Absorption and Glucose-Dependent Incretin Secretion
Valentin Gorboulev et al.
DIABETES (2012)
Functional characterisation of human SGLT-5 as a novel kidney-specific sodium-dependent sugar transporter
Rolf Grempler et al.
FEBS LETTERS (2012)
Inhibition of the mTOR/p70S6K pathway is not involved in the insulin-sensitizing effect of AMPK on cardiac glucose uptake
Audrey Ginion et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Effects of Administration Route, Dietary Condition, and Blood Glucose Level on Kinetics and Uptake of 18F-FDG in Mice
Koon-Pong Wong et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Biology of Human Sodium Glucose Transporters
Ernest M. Wright et al.
PHYSIOLOGICAL REVIEWS (2011)
Requirement for distinct vesicle-associated membrane proteins in insulin- and AMP-activated protein kinase (AMPK)-induced translocation of GLUT4 and CD36 in cultured cardiomyocytes
R. W. Schwenk et al.
DIABETOLOGIA (2010)
Functional effects of glucose transporters in human ventricular myocardium
Dirk von Lewinski et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
SGLT1, a novel cardiac glucose transporter, mediates increased glucose uptake in PRKAG2 cardiomyopathy
Sanjay K. Banerjee et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
Glucose-transporter-mediated positive inotropic effects in human myocardium of diabetic and nondiabetic patients
Dirk von Lewinski et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
SGLT1 is a novel cardiac glucose transporter that is perturbed in disease states
Sanjay K. Banerjee et al.
CARDIOVASCULAR RESEARCH (2009)
6-Fluoro-6-deoxy-D-glucose as a tracer of glucose transport
Bernard R. Landau et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Imino sugars are potent agonists of the human glucose sensor SGLT3
Andrew A. Voss et al.
MOLECULAR PHARMACOLOGY (2007)
Performance evaluation of the Philips MOSAIC small animal PET scanner
Marc C. Huisman et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Functional properties and genomics of glucose transporters
Feng-Qi Zhao et al.
CURRENT GENOMICS (2007)
AMPK activation restores the stimulation of glucose uptake in an in vitro model of insulin-resistant cardiomyocytes via the activation of protein kinase B
L Bertrand et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Phlorizin: a review
JRL Ehrenkranz et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2005)
SLC5A9/SGLT4, a new Na+-dependent glucose transporter, is an essential transporter for mannose, 1,5-anhydro-D-glucitol, and fructose
S Tazawa et al.
LIFE SCIENCES (2005)
Surprising versatility of Na+-glucose cotransporters:: SLC5
EM Wright et al.
PHYSIOLOGY (2004)
Glucose transport in the heart
ED Abel
FRONTIERS IN BIOSCIENCE-LANDMARK (2004)
Human cardiomyocytes express high level of Na+/glucose cotransporter 1 (SGLT1)
LB Zhou et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Loss of murine Na+/myo-inositol cotransporter leads to brain myo-inositol depletion and central apnea
GT Berry et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Identification of a novel Na+/myo-inositol cotransporter
MJ Coady et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Indinavir inhibits the glucose transporter isoform Glut4 at physiologic concentrations
H Murata et al.
AIDS (2002)
Differential regulation of mouse kidney sodium-dependent transporters mRNA by cadmiume
NM Tabatabai et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2001)
Share Paper
